Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert M Kalicki

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Blood Purification|May 22, 2008
Red cell survival in relation to changes in the hematocrit: more important than you thinkRobert M Kalicki, Dominik E Uehlinger
Anemia|May 9, 2013
The Validation of a New Visual Anaemia Evaluation Tool HemoHue HH1 in Patients with End-Stage Renal DiseaseRobert M Kalicki, Stefan Farese, Dominik E Uehlinger
Therapeutische Umschau. Revue Therapeutique|August 1, 2015
[Renal replacement therapies – Past, present and future]Robert M Kalicki, Sibylle Eicken, Suzan Dahdal, et al.
Journal of Pharmacokinetics and Pharmacodynamics|August 1, 2012
Modeling of red blood cell life-spans in hematologically normal populationsRocío Lledó-García, Robert M Kalicki, Dominik E Uehlinger, et al.
Thrombosis and Haemostasis|December 8, 2007
Use of the pentasaccharide fondaparinux as an anticoagulant during haemodialysisRobert M Kalicki, Fabienne Aregger, Lorenzo Alberio, et al.
Swiss Medical Weekly|November 1, 2018
Reality check: primary vascular access creation todayTabitha Jann, Thomas R Wyss, Brigitta Gahl, et al.
Artificial Organs|July 7, 2015
Clinical Validation of a Peritoneal Dialysis Prescription Model in the PatientOnLine SoftwareEmir Hodzic, Senija Rasic, Christian Klein, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Blood Purification|May 22, 2008
Red cell survival in relation to changes in the hematocrit: more important than you thinkRobert M Kalicki, Dominik E Uehlinger
Anemia|May 9, 2013
The Validation of a New Visual Anaemia Evaluation Tool HemoHue HH1 in Patients with End-Stage Renal DiseaseRobert M Kalicki, Stefan Farese, Dominik E Uehlinger
Therapeutische Umschau. Revue Therapeutique|August 1, 2015
[Renal replacement therapies – Past, present and future]Robert M Kalicki, Sibylle Eicken, Suzan Dahdal, et al.
Journal of Pharmacokinetics and Pharmacodynamics|August 1, 2012
Modeling of red blood cell life-spans in hematologically normal populationsRocío Lledó-García, Robert M Kalicki, Dominik E Uehlinger, et al.
Thrombosis and Haemostasis|December 8, 2007
Use of the pentasaccharide fondaparinux as an anticoagulant during haemodialysisRobert M Kalicki, Fabienne Aregger, Lorenzo Alberio, et al.
Swiss Medical Weekly|November 1, 2018
Reality check: primary vascular access creation todayTabitha Jann, Thomas R Wyss, Brigitta Gahl, et al.
Artificial Organs|July 7, 2015
Clinical Validation of a Peritoneal Dialysis Prescription Model in the PatientOnLine SoftwareEmir Hodzic, Senija Rasic, Christian Klein, et al.
Pageof 1